VICINI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.114
EU - Europa 2.087
AS - Asia 1.772
SA - Sud America 246
Continente sconosciuto - Info sul continente non disponibili 59
AF - Africa 45
OC - Oceania 6
AN - Antartide 1
Totale 7.330
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.016
IT - Italia 815
SG - Singapore 526
CN - Cina 504
GB - Regno Unito 433
BR - Brasile 184
VN - Vietnam 169
HK - Hong Kong 166
SE - Svezia 155
IE - Irlanda 148
DE - Germania 129
BD - Bangladesh 110
FI - Finlandia 82
RU - Federazione Russa 65
KR - Corea 62
FR - Francia 54
IN - India 51
CA - Canada 48
ID - Indonesia 42
NL - Olanda 40
UA - Ucraina 38
MX - Messico 27
AR - Argentina 24
TR - Turchia 21
JP - Giappone 20
BG - Bulgaria 16
BE - Belgio 13
ES - Italia 13
AE - Emirati Arabi Uniti 12
AT - Austria 12
CO - Colombia 12
LT - Lituania 12
MY - Malesia 12
PL - Polonia 12
ZA - Sudafrica 12
MK - Macedonia 10
PH - Filippine 10
PK - Pakistan 10
CL - Cile 9
IQ - Iraq 9
SA - Arabia Saudita 9
CR - Costa Rica 8
CZ - Repubblica Ceca 8
GR - Grecia 7
AU - Australia 6
CH - Svizzera 6
EC - Ecuador 6
KE - Kenya 6
VE - Venezuela 6
MA - Marocco 5
TH - Thailandia 5
TN - Tunisia 5
UZ - Uzbekistan 5
AL - Albania 4
ET - Etiopia 4
JO - Giordania 4
NG - Nigeria 4
RS - Serbia 4
CY - Cipro 3
DO - Repubblica Dominicana 3
EG - Egitto 3
IL - Israele 3
BH - Bahrain 2
HN - Honduras 2
IR - Iran 2
IS - Islanda 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PY - Paraguay 2
RO - Romania 2
A1 - Anonimo 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
AQ - Antartide 1
AZ - Azerbaigian 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
HR - Croazia 1
HT - Haiti 1
JM - Giamaica 1
KH - Cambogia 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
MD - Moldavia 1
MG - Madagascar 1
MN - Mongolia 1
MQ - Martinica 1
MZ - Mozambico 1
NP - Nepal 1
Totale 7.267
Salva come PNG Salva come JPEG
Città #
Ashburn 365
Singapore 359
Santa Clara 333
Southend 303
San Jose 210
Fairfield 184
Chandler 164
Hong Kong 163
Hefei 158
Dublin 140
Council Bluffs 106
Ann Arbor 103
Woodbridge 103
Beijing 92
Houston 79
Nyköping 77
Seattle 76
Los Angeles 75
Wilmington 70
Dearborn 62
Jacksonville 62
London 62
Milan 62
Ho Chi Minh City 59
Bologna 58
New York 58
Cambridge 57
Modena 57
Seoul 55
Helsinki 52
The Dalles 47
Hanoi 43
Rome 38
Jakarta 36
Chicago 34
Munich 31
Shanghai 30
Reggio Emilia 27
Boardman 26
San Diego 25
Dallas 20
Lauterbourg 19
Bremen 18
Orem 18
São Paulo 17
Buffalo 16
Eugene 16
Frankfurt am Main 16
Moscow 16
Princeton 16
Sofia 16
Turin 16
Turku 16
Bari 15
Toronto 15
Florence 14
Tokyo 14
Columbus 13
Brussels 12
Parma 12
Mexico City 11
Palermo 11
Redwood City 11
Amsterdam 10
Hillsboro 10
Nuremberg 10
Warsaw 10
Izmir 9
Kent 9
Lappeenranta 9
Redondo Beach 9
Salt Lake City 9
Denver 8
Falls Church 8
Haiphong 8
Atlanta 7
Belo Horizonte 7
Boston 7
Chennai 7
Montreal 7
Phoenix 7
Poplar 7
Tampa 7
Brooklyn 6
Buenos Aires 6
Chengdu 6
Ferrara 6
Fulham 6
Kuala Lumpur 6
Las Vegas 6
Monterrey 6
Newark 6
Paris 6
San José 6
Stockholm 6
Brasília 5
Brescia 5
Catania 5
Da Nang 5
Fremont 5
Totale 4.751
Salva come PNG Salva come JPEG
Nome #
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 509
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVO 499
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study. 423
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 413
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 400
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial . 363
"It's All COVID's Fault!": Symptoms of Distress among Workers in an Italian General Hospital during the Pandemic 349
Double-blind, placebo-controlled, multicentric randomized phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal HER2-negative, hormone receptor-positive operable breast cancer 321
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 290
PREVALENCE OF NODE NEGATIVE AND SMALL SIZE TUMORS IN A NATIONAL, RANDOMISED, PHASE III ADJUVANT TRIAL IN HER2 + EARLY BREAST CANCER (SHORT-HER STUDY) 280
9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio 278
Progestogens for Maintenance Tocolysis in Women With a Short Cervix: A Randomized Controlled Trial 278
Preoperative carboplatin-paclitaxel-bevacizumab in triple negative breast cancer: Final results of the phase II CA.Pa.Be study 271
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): A structured summary of a study protocol 268
Biomarker expression and survival after primary chemotherapy for breast cancer. 257
Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trial 247
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVE: ANALISI PRELIMINARE DELLE TOSSICITA’ 225
Pattern of distant relapse according to intrinsic molecular subtype in patients with HER2-positive breast cancer: a combined analysis of ShortHER, CherLOB, and two institutional cohorts 216
Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial 214
Rapamycin treatment for amyotrophic lateral sclerosis protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) 204
Cosmetic Results and Side Effects of Accelerated Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Carcinoma of the Breast: The Randomized Phase III IRMA Trial 197
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer 185
Physical activity practiced at a young age is associated with a less severe subsequent clinical presentation in facioscapulohumeral muscular dystrophy 178
Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials 165
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2â € "Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial 156
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis 144
Totale 7.330
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.314
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.314
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022341 0 0 26 12 10 26 16 31 51 23 103 43
2022/2023651 53 61 40 46 57 62 16 50 195 12 27 32
2023/2024577 31 26 33 57 54 54 63 73 36 46 51 53
2024/20251.426 37 25 45 110 254 230 101 78 155 51 129 211
2025/20262.608 216 103 191 284 389 128 337 110 219 293 229 109
2026/2027296 94 159 43 0 0 0 0 0 0 0 0 0
Totale 7.330